PCA
GILD icon

Personal Capital Advisors’s Gilead Sciences GILD Stock Holding History

Personal Capital Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$624K Sell
7,266
-800
-10% -$63.4K ﹤0.01% 272
2022
Q3 		$498K Buy
8,066
+16
+0.2% +$1.01K ﹤0.01% 285
2022
Q2 		$498K Buy
8,050
+145
+2% +$8.98K ﹤0.01% 275
2022
Q1 		$470K Sell
7,905
-440
-5% -$28.1K ﹤0.01% 316
2021
Q4 		$606K Buy
8,345
+176
+2% +$12.1K ﹤0.01% 308
2021
Q3 		$571K Buy
8,169
+3,124
+62% +$219K ﹤0.01% 295
2021
Q2 		$347K Sell
5,045
-560
-10% -$37.4K ﹤0.01% 369
2021
Q1 		$362K Sell
5,605
-167
-3% -$10.8K ﹤0.01% 357
2020
Q4 		$336K Buy
5,772
+529
+10% +$31.9K ﹤0.01% 362
2020
Q3 		$331K Buy
5,243
+144
+3% +$9.99K ﹤0.01% 316
2020
Q2 		$392K Sell
5,099
-959
-16% -$73.5K ﹤0.01% 269
2020
Q1 		$406K Buy
6,058
+319
+6% +$22K ﹤0.01% 266
2019
Q4 		$373K Buy
5,739
+633
+12% +$41.2K ﹤0.01% 300
2019
Q3 		$323K Sell
5,106
-530,048
-99% -$34.6M ﹤0.01% 285
2019
Q2 		$36.2M Buy
535,154
+63,925
+14% +$4.21M 0.37% 71
2019
Q1 		$30.6M Buy
471,229
+71,319
+18% +$4.74M 0.34% 76
2018
Q4 		$25M Sell
399,910
-65,400
-14% -$4.57M 0.33% 74
2018
Q3 		$35.9M Buy
465,310
+25,825
+6% +$1.95M 0.46% 53
2018
Q2 		$31.1M Buy
439,485
+48,741
+12% +$3.44M 0.44% 59
2018
Q1 		$29.5M Buy
+390,744
New +$31.1M 0.46% 54

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Personal Capital Advisors's GILD Position: Q4 2022 in Review

Personal Capital Advisors reduced its Gilead Sciences (GILD) stake by 9.9% in Q4 2022, selling an estimated $63.4K and leaving 7,266 shares worth $624K. The position accounts for ﹤0.01% of the portfolio, ranked #272.

Personal Capital Advisors first reported a position in GILD in Q1 2018 and has held it in 20 quarters since. The position peaked at $36.2M in Q2 2019. 1,768 funds tracked by Wall St. Rank hold GILD as of Q4 2022.

  • Personal Capital Advisors held 7,266 shares of Gilead Sciences worth $624K as of Q4 2022.
  • Personal Capital Advisors sold 800 Gilead Sciences shares in Q4 2022, an estimated $63.4K.
  • Gilead Sciences made up ﹤0.01% of Personal Capital Advisors's portfolio in Q4 2022, its #272 holding.
  • Personal Capital Advisors first reported a position in Gilead Sciences in Q1 2018 and has held it in 20 quarters since.
  • Personal Capital Advisors's Gilead Sciences position peaked at $36.2M in Q2 2019.
  • 1,768 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.

Based on Personal Capital Advisors's 13F filing for Q4 2022, filed 15 Feb 2023.